Who owns Cue Biopharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CUE from SEC Form 13F filings across 50 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 50 institutions disclosed 1.7M shares of Cue Biopharma, Inc. worth $52.2M — about 26.1% of shares outstanding; the largest disclosed holder is Bleichroeder LP. Source: SEC Form 13F filings, parsed by EvidInvest.
50
13F holders
$52.2M
value, 2026 filers
26.1%
of shares outstanding (1.7M sh)
49
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CUE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LPNEW | 370,682 | $11.7M | 2.1% | 5.8% | new |
| 2 | Driehaus Capital Management LLCNEW | 292,144 | $9.2M | 0.1% | 4.6% | new |
| 3 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 161,700 | $5.1M | 0.0% | 2.6% | new |
| 4 | Ikarian Capital, LLCNEW | 104,364 | $3.3M | 0.4% | 1.6% | new |
| 5 | Tetragon Partners GP LtdNEW | 93,819 | $3.0M | 0.5% | 1.5% | new |
| 6 | STEMPOINT CAPITAL LPNEW | 66,995 | $2.1M | 0.4% | 1.1% | new |
| 7 | BlackRock, Inc.NEW | 57,807 | $1.8M | 0.0% | 0.9% | new |
| 8 | ADAR1 Capital Management, LLCNEW | 55,193 | $1.7M | 0.1% | 0.9% | new |
| 9 | Lion Point Capital, LPNEW | 52,928 | $1.7M | 8.0% | 0.8% | new |
| 10 | Squadron Capital Management LLCNEW | 50,000 | $1.6M | 0.5% | 0.8% | new |
| 11 | DIADEMA PARTNERS LPNEW | 48,369 | $1.5M | 0.2% | 0.8% | new |
| 12 | GEODE CAPITAL MANAGEMENT, LLCNEW | 47,824 | $1.5M | 0.0% | 0.8% | new |
| 13 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 31,459 | $992,846 | 0.0% | 0.5% | new |
| 14 | UBS Group AGNEW | 26,700 | $842,652 | 0.0% | 0.4% | new |
| 15 | CITADEL ADVISORS LLCNEW | 25,633 | $808,977 | 0.0% | 0.4% | new |
| 16 | VANGUARD FIDUCIARY TRUST CONEW | 24,476 | $772,463 | 0.0% | 0.4% | new |
| 17 | Texas Capital Bank Wealth Management Services IncNEW | 22,881 | $722,124 | 0.0% | 0.4% | new |
| 18 | RENAISSANCE TECHNOLOGIES LLCNEW | 14,689 | $463,585 | 0.0% | 0.2% | new |
| 19 | STATE STREET CORPNEW | 14,176 | $447,395 | 0.0% | 0.2% | new |
| 20 | Persistent Asset Partners LtdNEW | 12,332 | $389,198 | 0.1% | 0.2% | new |
| 21 | Robertson Stephens Wealth Management, LLCNEW | 11,133 | $351,357 | 0.0% | 0.2% | new |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 11,003 | $347,255 | 0.0% | 0.2% | new |
| 23 | Seven Fleet Capital Management LPNEW | 10,702 | $337,755 | 0.1% | 0.2% | new |
| 24 | NORTHERN TRUST CORPNEW | 9,122 | $287,890 | 0.0% | 0.1% | new |
| 25 | ADVISORY RESEARCH INCNEW | 8,573 | $270,564 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.